GLP-1 receptor agonists and SGLT2 inhibitors, two classes of medications most commonly prescribed to treat Type 2 diabetes or weight loss, may reduce the risk of heart attack, second strokes and death ...

Q3 2024 Earnings Call Transcript November 9, 2024 Operator: Good morning. My name is Alan, and I will be your conference operator today. At this time, I would like to welcome everyone to the Amylyx ...

A mum is warning people not to take skinny jabs from 'strangers on the internet' - after nearly dying when she accidentally injected 'five times' the recommended dose sent as a 'freebie' over ...

Novo Nordisk's stock has dropped to $110 per share, but operational performance remains strong. See why I believe we are at ...

In September, the company officially relocated its headquarters from a 114,000-square-foot space in New York City to a ...

The GIP receptor agonist part works very similarly, mimicking the GIP hormone, which is also released after eating to trigger ...

Conditions are getting a bit more challenging for the drugmaker.

There's a new player in the running game, and it's not the latest carbon-plated shoe or fancy GPS watch. GLP-1 medications ...

Analyzing H&H's Q3 results and investment strategy in the healthcare industry, highlighting undervaluation and raising the ...

In general, when a person prepares for a surgery, the guidance is to fast before going under anesthesia. But for patients on ...